These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 7884761)

  • 1. A review of the mechanisms of oral tolerance and immunotherapy.
    Sosroseno W
    J R Soc Med; 1995 Jan; 88(1):14-7. PubMed ID: 7884761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular Components and Mechanisms of Oral Tolerance Induction.
    Rezende RM; Weiner HL
    Crit Rev Immunol; 2018; 38(3):207-231. PubMed ID: 30004858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+CD25+ regulatory T-cell therapy for allergy, autoimmune disease and transplant rejection.
    Jiang S; Lechler RI
    Inflamm Allergy Drug Targets; 2006 Dec; 5(4):239-42. PubMed ID: 17168794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences and similarities between sublingual immunotherapy of allergy and oral tolerance.
    Moingeon P; Mascarell L
    Semin Immunol; 2017 Apr; 30():52-60. PubMed ID: 28760498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural and induced regulatory T cells: targets for immunotherapy of autoimmune disease and allergy.
    Nicolson KS; Wraith DC
    Inflamm Allergy Drug Targets; 2006 Sep; 5(3):141-8. PubMed ID: 16918477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological mechanisms involved in experimental peptide immunotherapy of T-cell-mediated diseases.
    Wauben MH
    Crit Rev Immunol; 2000; 20(6):451-69. PubMed ID: 11396681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scientific rationale for the Finnish Allergy Programme 2008-2018: emphasis on prevention and endorsing tolerance.
    von Hertzen LC; Savolainen J; Hannuksela M; Klaukka T; Lauerma A; Mäkelä MJ; Pekkanen J; Pietinalho A; Vaarala O; Valovirta E; Vartiainen E; Haahtela T
    Allergy; 2009 May; 64(5):678-701. PubMed ID: 19383025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant allergen and peptide-based approaches for allergy prevention by oral tolerance.
    Campana R; Huang HJ; Freidl R; Linhart B; Vrtala S; Wekerle T; Karaulov A; Valenta R
    Semin Immunol; 2017 Apr; 30():67-80. PubMed ID: 28939389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant bet v 1, the major birch pollen allergen, in a murine model of type I allergy.
    Wiedermann U; Jahn-Schmid B; Bohle B; Repa A; Renz H; Kraft D; Ebner C
    J Allergy Clin Immunol; 1999 Jun; 103(6):1202-10. PubMed ID: 10359907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral tolerance: a biologically relevant pathway to generate peripheral tolerance against external and self antigens.
    Friedman A; al-Sabbagh A; Santos LM; Fishman-Lobell J; Polanski M; Das MP; Khoury SJ; Weiner HL
    Chem Immunol; 1994; 58():259-90. PubMed ID: 8011155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic manipulation of immune tolerance in allergic disease.
    Akdis M; Akdis CA
    Nat Rev Drug Discov; 2009 Aug; 8(8):645-60. PubMed ID: 19644474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies for the therapeutic induction of tolerance.
    Waldmann H; Qin S; Cobbold SP
    Immunol Ser; 1993; 59():85-99. PubMed ID: 8461402
    [No Abstract]   [Full Text] [Related]  

  • 13. Potentiation of immunological tolerance induction in adult mice by co-administration of pooled normal IgG and oral tolerogens: a potential therapeutic approach for autoimmune diseases.
    Mengel J; Fávaro P; Meyer A; Motta V; de Alencar R; Postól E; Cardillo F
    Med Hypotheses; 2005; 64(5):978-85. PubMed ID: 15780495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral tolerance: an updated review.
    Rezende RM; Weiner HL
    Immunol Lett; 2022 May; 245():29-37. PubMed ID: 35395272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of Oral Tolerance with Transgenic Plants Expressing Antigens for Prevention/Treatment of Autoimmune, Allergic and Inflammatory Diseases.
    Ma S; Liao YC; Jevnikar AM
    Curr Pharm Biotechnol; 2015; 16(11):1002-11. PubMed ID: 26306744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of autoimmune disease by oral tolerance to autoantigens.
    Whitacre CC; Gienapp IE; Meyer A; Cox KL; Javed N
    Clin Immunol Immunopathol; 1996 Sep; 80(3 Pt 2):S31-9. PubMed ID: 8811061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral tolerance in the treatment of rheumatoid arthritis.
    Toussirot EA
    Curr Drug Targets Inflamm Allergy; 2002 Mar; 1(1):45-52. PubMed ID: 14561205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of Aeroallergen Immunotherapy: Subcutaneous Immunotherapy and Sublingual Immunotherapy.
    Ozdemir C; Kucuksezer UC; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2016 Feb; 36(1):71-86. PubMed ID: 26617228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens.
    Weiner HL; Friedman A; Miller A; Khoury SJ; al-Sabbagh A; Santos L; Sayegh M; Nussenblatt RB; Trentham DE; Hafler DA
    Annu Rev Immunol; 1994; 12():809-37. PubMed ID: 8011298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of oral tolerance to the treatment of autoimmune diseases--active suppression and bystander suppression].
    Matsui M
    Nihon Rinsho; 1997 Jun; 55(6):1537-42. PubMed ID: 9200945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.